on 8 Dec 2023
Last Applicant/ Owned by
KRINGLE PHARMA INC.
2F Saito Bio Incubator,7-7-15, Saitoasagi,Ibaraki- shiOsaka 567-0085
JP
Serial Number
2131113 filed on 7th Jul 2021
Registration Number
TMA1213071 registered on 8th Dec 2023
Registration expiry Date
7th Jul 2031Correspondent Address
MARKS & CLERK
33 Yonge Street, Suite 300Toronto
ONTARIO
CA
M5E1G4
Trademark usage description
pharmaceutical preparations for the treatment of central nervous system (cns) diseases, renal disease, acute and chronic liver diseases, fulminant hep Read More11
2131113
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 48 on 9th Aug 2023 | Agent Changed |
Submitted for opposition 22 on 14th Dec 2022 | Search Recorded |
Submitted for opposition 20 on 14th Dec 2022 | Examiner's First Report |
Submitted for opposition 223 on 14th Dec 2022 | Total Provisional Refusal |
Submitted for opposition 256 on 4th Jul 2022 | Notification of Possible Opposition Sent |
Submitted for opposition 257 on 2th Sept 2021 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 1st Sept 2021 | Created |
Submitted for opposition 31 on 1st Sept 2021 | Formalized |
Submitted for opposition 228 on 7th Jul 2021 | International Registration |
Submitted for opposition 30 on 7th Jul 2021 | Filed |